CANCER SCIENCE

Abbr. CANCER SCI ·JAPAN ·Frequency Monthly ·Avg. articles/yr 228 articles

4.3

Latest IF

2.00%

Self-citation

约62.5%

Submission difficulty

Avg. 2.0 months

Review cycle

About Journal

CANCER SCIENCE是一本国际性肿瘤学期刊，ISSN号为1347-9032，由日本癌症学会（Japanese Cancer Association）出版，每月发行一次，出版地为日本。该期刊由Wiley出版社负责全球发行，2022年影响因子为5.7，属于非开放获取（非OA）期刊，被SCI收录，在中科院分区中通常位于医学大类2区或肿瘤学小类3区。其发文特点聚焦于肿瘤学基础与临床研究，涵盖肿瘤分子机制、治疗耐药性、免疫治疗、流行病学及转化医学等领域，尤其鼓励来自亚洲地区的研究成果。杂志质量较高，审稿流程严格，但需注意其近年自引率略有上升，可能存在潜在风险，投稿前建议结合最新年度引用报告评估其学术影响力。总体而言，该期刊是肿瘤学领域具有国际认可度的专业平台。

IF Trend

Recent Articles

Comprehensive Genomic Profiling Beyond Driver Testing in Non‐Squamous Non‐Small Cell Lung Cancer With Known Drivers 2026-09-22

Triangulating Evidence on Serum Uric Acid and Cancer Risk: Consistent Inverse Associations With Lung Cancer 2026-09-21

Cord Blood‐Derived Fibroblast Activation Protein‐Targeted Chimeric Antigen Receptor Natural Killer Cells Persist in Vivo 2026-09-21

Real‐World Achievement of Guideline‐Concordant Treatment and Survival in Osteosarcoma: A Nationwide Registry Study 2026-09-18

Advances in Radiotherapy for Neoadjuvant Therapy of Stage <scp>III</scp> Non‐Small Cell Lung Cancer 2026-09-18

Limitations of <scp>PIV</scp> Biomarker Analysis Related to Chemoradiotherapy and Unadjusted Confounders 2026-09-18

Advances in Spatial Heterogeneity and Cellular Localization Specificity of Intratumoral Bacteria 2026-09-14

Clinical Significance of a Cell‐Of‐Origin‐Based Classification in Pancreatic Ductal Adenocarcinoma 2026-09-13

Integrated Analysis of <scp>HER2</scp> Expression and <scp> <i>ERBB2</i> </scp> Alterations in Bladder Cancer 2026-09-13

<scp>EPHX2</scp> Loss Promotes <scp>CRC</scp> Migration via <scp>EET</scp> ‐Dependent Chemokine Elevation and Mitochondrial Defect 2026-09-13